Linda Rydén1, Ulrik Sartipy2, Marie Evans2, Martin J Holzmann2. 1. From the Department of Anaesthesiology, Surgical Services, and Intensive Care Medicine (L.R.), Department of Cardiothoracic Surgery and Anaesthesiology (U.S.), Department of Nephrology (M.E.), and Department of Emergency Medicine (M.J.H.), Karolinska University Hospital, Stockholm, Sweden; Swedish Renal Registry (M.E.), Jönköping, Sweden; and Department of Molecular Medicine and Surgery (U.S.), CLINTEC (M.E.), and Department of Internal Medicine (L.R., M.J.H.), Karolinska Institutet, Stockholm, Sweden. linda.ryden@karolinska.se. 2. From the Department of Anaesthesiology, Surgical Services, and Intensive Care Medicine (L.R.), Department of Cardiothoracic Surgery and Anaesthesiology (U.S.), Department of Nephrology (M.E.), and Department of Emergency Medicine (M.J.H.), Karolinska University Hospital, Stockholm, Sweden; Swedish Renal Registry (M.E.), Jönköping, Sweden; and Department of Molecular Medicine and Surgery (U.S.), CLINTEC (M.E.), and Department of Internal Medicine (L.R., M.J.H.), Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG) and is associated with adverse outcomes. However, the relationship between AKI after CABG and the long-term risk of end-stage renal disease (ESRD) is unknown. METHODS AND RESULTS: This study included 29 330 patients who underwent primary isolated CABG in Sweden between 2000 and 2008. AKI was classified according to the Acute Kidney Injury Network (AKIN) classification: stage 1, >0.3 mg/dL (>26 μmol/L) or 50% to 100% increase; stage 2, 100% to 200% increase; and stage 3, >200% increase from the preoperative to postoperative serum creatinine level. Cox proportional hazards regression analysis was used to calculate hazard ratios with 95% confidence intervals for ESRD in AKIN stage 1 and stage 2 to 3. Postoperative AKI occurred in 13% of patients. During a mean follow-up of 4.3±2.4 years, 123 patients (0.4%) developed ESRD, including 50 (1.6%) in AKIN stage 1, 29 (5.2%) in AKIN stage 2 to 3, and 44 (0.2%) without AKI after CABG. After multivariable adjustment, the hazard ratio for ESRD was 2.92 (95% confidence interval, 1.87-4.55) for AKIN stage 1 and 3.81 (95% confidence interval, 2.14-6.79) for AKIN stage 2 to 3. CONCLUSIONS: This nationwide study of patients who underwent CABG found that a small increase in the postoperative serum creatinine level was associated with an almost 3-fold increase in the long-term risk of ESRD after adjustment for a number of confounders, including preoperative renal function.
BACKGROUND:Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG) and is associated with adverse outcomes. However, the relationship between AKI after CABG and the long-term risk of end-stage renal disease (ESRD) is unknown. METHODS AND RESULTS: This study included 29 330 patients who underwent primary isolated CABG in Sweden between 2000 and 2008. AKI was classified according to the Acute Kidney Injury Network (AKIN) classification: stage 1, >0.3 mg/dL (>26 μmol/L) or 50% to 100% increase; stage 2, 100% to 200% increase; and stage 3, >200% increase from the preoperative to postoperative serum creatinine level. Cox proportional hazards regression analysis was used to calculate hazard ratios with 95% confidence intervals for ESRD in AKIN stage 1 and stage 2 to 3. Postoperative AKI occurred in 13% of patients. During a mean follow-up of 4.3±2.4 years, 123 patients (0.4%) developed ESRD, including 50 (1.6%) in AKIN stage 1, 29 (5.2%) in AKIN stage 2 to 3, and 44 (0.2%) without AKI after CABG. After multivariable adjustment, the hazard ratio for ESRD was 2.92 (95% confidence interval, 1.87-4.55) for AKIN stage 1 and 3.81 (95% confidence interval, 2.14-6.79) for AKIN stage 2 to 3. CONCLUSIONS: This nationwide study of patients who underwent CABG found that a small increase in the postoperative serum creatinine level was associated with an almost 3-fold increase in the long-term risk of ESRD after adjustment for a number of confounders, including preoperative renal function.
Authors: Yang Chen; Gail J Harty; Ye Zheng; Seethalakshmi R Iyer; Shinobu Sugihara; S Jeson Sangaralingham; Tomoko Ichiki; Joseph P Grande; Hon-Chi Lee; Xiaoli Wang; John C Burnett Journal: Circ Res Date: 2019-05-10 Impact factor: 17.367
Authors: Jonathan Himmelfarb; Glenn M Chertow; Peter A McCullough; Thierry Mesana; Andrew D Shaw; Thoralf M Sundt; Craig Brown; David Cortville; François Dagenais; Benoit de Varennes; Manuel Fontes; Jerome Rossert; Jean-Claude Tardif Journal: J Am Soc Nephrol Date: 2017-12-04 Impact factor: 10.121
Authors: Abduzhappar Gaipov; Miklos Z Molnar; Praveen K Potukuchi; Keiichi Sumida; Zoltan Szabo; Oguz Akbilgic; Elani Streja; Connie M Rhee; Santhosh K G Koshy; Robert B Canada; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: Nephrol Dial Transplant Date: 2019-11-01 Impact factor: 5.992
Authors: Cynthia C Lim; Chieh Suai Tan; Cynthia M L Chia; Ann Kheng Tan; Jason C J Choo; Manish Kaushik; Han Khim Tan Journal: Cardiorenal Med Date: 2015-04-16 Impact factor: 2.041
Authors: Alexander A Brescia; Xiaoting Wu; Gaetano Paone; Michael Heung; Theron A Paugh; Kenneth G Shann; David C Fitzgerald; Timothy A Dickinson; David Sturmer; Jeffrey Chores; Andrew L Pruitt; Haley Allgeyer; Sim Uppal; Min Zhang; Himanshu J Patel; Richard L Prager; Donald S Likosky Journal: J Thorac Cardiovasc Surg Date: 2019-03-29 Impact factor: 5.209
Authors: Marta Martin-Lorenzo; Laura Gonzalez-Calero; Angeles Ramos-Barron; Maria D Sanchez-Niño; Carlos Gomez-Alamillo; Juan Manuel García-Segura; Alberto Ortiz; Manuel Arias; Fernando Vivanco; Gloria Alvarez-Llamas Journal: J Mol Med (Berl) Date: 2017-10-04 Impact factor: 4.599